Literature DB >> 19880622

Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level.

A A Velayati, P Farnia, M R Masjedi, T A Ibrahim, P Tabarsi, R Z Haroun, H O Kuan, J Ghanavi, P Farnia, M Varahram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19880622     DOI： 10.1183/09031936.00081909

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  33 in total

1.  Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Authors:  Andrés Obregón-Henao; Crystal Shanley; María Verónica Bianco; Angel A Cataldi; Randall J Basaraba; Ian M Orme; Fabiana Bigi
Journal:  Vaccine       Date:  2011-04-22       Impact factor: 3.641

2.  Growth and cell-division in extensive (XDR) and extremely drug resistant (XXDR) tuberculosis strains: transmission and atomic force observation.

Authors:  Parissa Farnia; Reza Masjedi Mohammad; Muayad Aghali Merza; Payam Tabarsi; Gennadii Konstantinovich Zhavnerko; Tengku Azmi Ibrahim; Ho Oi Kuan; Jalladein Ghanavei; Poopak Farnia; Reza Ranjbar; Nikolai Nikolaevich Poleschuyk; Leonid Petrovich Titov; Parviz Owlia; Mehadi Kazampour; Mohammad Setareh; Muaryam Sheikolslami; Giovanni Battista Migliori; Ali Akbar Velayati
Journal:  Int J Clin Exp Med       Date:  2010-09-30

3.  A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs.

Authors:  David A Hokey; Robert Wachholder; Patricia A Darrah; Diane L Bolton; Dan H Barouch; Krystal Hill; Veerabadran Dheenadhayalan; Stephan Schwander; C Steven Godin; Macaya Douoguih; Maria Grazia Pau; Robert A Seder; Mario Roederer; Jerald C Sadoff; Donata Sizemore
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Response.

Authors:  Ali Akbar Velayati; Parissa Farnia; Mehdi Mirsaeidi
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

5.  Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis.

Authors:  Mark W Majewski; Sanghyun Cho; Patricia A Miller; Scott G Franzblau; Marvin J Miller
Journal:  Bioorg Med Chem Lett       Date:  2015-05-20       Impact factor: 2.823

6.  The totally drug resistant tuberculosis (TDR-TB).

Authors:  Ali Akbar Velayati; Parissa Farnia; Mohammad Reza Masjedi
Journal:  Int J Clin Exp Med       Date:  2013-04-12

7.  Improved mycobacterial tetracycline inducible vectors.

Authors:  Kerstin J Williams; Graham Joyce; Brian D Robertson
Journal:  Plasmid       Date:  2010-04-29       Impact factor: 3.466

Review 8.  The current state of tuberculosis vaccines.

Authors:  David A Hokey; Ann Ginsberg
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

Review 9.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

10.  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Authors:  Crystal A Shanley; Gregory C Ireton; Susan L Baldwin; Rhea N Coler; Steven G Reed; Randall J Basaraba; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-09-07       Impact factor: 3.131
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.